Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cracking the cytokine code in psoriasis

Brian J Nickoloff

    Nature Medicine
    |March 8, 2007
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis.

    The Journal of dermatological treatment·2026
    Same author

    Comparative Molecular Analysis of IL-17A and IL-23 Pathway Inhibition in Moderate-to-Severe Psoriasis: 4-Week Results from IXORA-R.

    The Journal of investigative dermatology·2025
    Same author

    Lebrikizumab Rapidly Lowers Inflammatory Biomarkers with Clinical Correlations in Moderate-to-Severe Atopic Dermatitis.

    Dermatology and therapy·2025
    Same author

    Cracking the cytokine code in atopic dermatitis reveals IL-13 as dominant driver of disease activity.

    Journal of dermatological science·2023
    Same author

    Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19.

    The Journal of allergy and clinical immunology·2020
    Same author

    Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

    EMBO molecular medicine·2020